A total of 63.2 % of the patients in the liraglutide group as compared with 27.1 % in the placebo group lost at least 5 % of their body weight ( P < 0.001 ) , and 33.1 % and 10.6 % , respectively , lost more than 10 % of their body weight ( P < 0.001 ) .